Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Cytotherapy|March 25, 2022
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomesAlice Bertaina, Allistair Abraham, Carmem Bonfim, et al.
Transfusion Medicine (Oxford, England)|March 23, 2022
Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a caseAlexander Rankin, Jennifer Webb, Robert Sheppard Nickel
Cytotherapy|December 9, 2021
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantationAlexis Leonard, Alice Bertaina, Carmem Bonfim, et al.
British Journal of Haematology|November 2, 2019
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell diseaseRobert S Nickel, John T Horan, Allistair Abraham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2017
Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-ThalassemiaHui Fen Zhao, Allistair Abraham, Yoon-Sang Kim, et al.
Transfusion Medicine Reviews|November 12, 2025
Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion SupportZaina Inam, HyoJeong Han, Jennifer Webb, et al.
Atherosclerosis. Supplements|July 26, 2008
Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivityJoanne Hsieh, Amanda A Hayashi, Jennifer Webb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2017
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell DiseaseAllistair Abraham, Matthew Hsieh, Mary Eapen, et al.
Cytotherapy|December 6, 2023
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyondSafia Belbachir, Allistair Abraham, Akshay Sharma, et al.
Cytotherapy|June 15, 2022
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatmentMaja Stanojevic, Alice Bertaina, Carmem Bonfim, et al.
Pageof 11